Fatal acute hepatic failure induced by danazol in a patient with endometriosis and aplastic anemia

Journal of Gastroenterology

Volumn 36, Issue 11, 2001, Pages 783-786

  Hayashi, T ^a   Takahashi, T ^a   Minami, T ^a   Akaike, J ^a   Kasahara, K ^a   Adachi, M ^a   Hinoda, Y ^a   Takahashi, S ^a   Hirayama, T ^a   Imai, K ^a  

^a DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

Aplastic anemia; Cyclosporin; Drug interaction

Indexed keywords

CYCLOSPORIN A; DANAZOL; GRANULOCYTE COLONY STIMULATING FACTOR; MEPREDNISONE; THYMOCYTE ANTIBODY;

ACUTE HEPATITIS; ADULT; APLASTIC ANEMIA; ARTICLE; AUTOPSY; CASE REPORT; CAUSE OF DEATH; COMORBIDITY; DISEASE SEVERITY; DRUG POTENTIATION; DRUG PULSE THERAPY; ENDOMETRIOSIS; EPIGASTRIC PAIN; FATALITY; FEMALE; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; LIVER FAILURE; LIVER INJURY; LIVER NECROSIS; PANCYTOPENIA; PATIENT REFERRAL; PRIORITY JOURNAL; RECURRENT DISEASE; TREATMENT FAILURE; VAGINA BLEEDING;

ANEMIA, APLASTIC; CYCLOSPORINE; DANAZOL; ENDOMETRIOSIS; ESTROGEN ANTAGONISTS; FATAL OUTCOME; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LIVER FAILURE, ACUTE; MIDDLE AGED;

EID: 0035206670     PISSN: 09441174     EISSN: None     Source Type: Journal    
DOI: 10.1007/s005350170022     Document Type: Article

References (10)

1. Danazol for the treatment of idiopathic thrombocytopenic purpura
2. Aplastic anemia
3. Danazol: Endocrine pharmacology and therapeutic applications
4. Cyclosporin toxicity at therapeutic blood levels and cytochrome P-450 IIIA
5. Fulminant hepatic failure associated with aplastic anemia after treatment with danazol. Case report
6. Cyclosporin interaction with danazol and norethisterone
7. Possible cyclosporin-danazol interaction in a patient with aplastic anaemia
8. The morphologic spectrum of halothane-induced hepatic injury: Analysis of 77 cases
9. Xenobiotic-induced hepatotoxicity: Mechanisms of liver injury and methods of monitoring hepatic function